ロード中...
Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.
The effect of a six-week course of spironolactone 300 mg/day was examined in 25 unselected patients with essential hypertension. In the blood spironolactone produced a significant rise in urea and potassium concentrations and a fall in sodium and bicarbonate concentrations. In six patients blood pre...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1976
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1639136/ https://ncbi.nlm.nih.gov/pubmed/766908 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|